Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis

Summary

A randomized double blind clinical trial to assess efficacy of leflunomide in treatment of refractory juvenile idiopathic arthritis. Patients are randomly divided into two groups. In group 1 leflunomide and in group 2 placebos will be added to conventional treatment for three months. therapeutic responses will be evaluated by ACRpedi (American College of Rheumatology Pediatric) scores every 4 weeks.

Timeline

Start

2013-06

Primary completion

2014-06

Completion

2014-12

Drugs

Indications